Molecular genetics of human hypertension

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 3, 2000, Pages 259-266

  Luft, Friedrich C ^a  

^a FRANZ VOLHARD CLINIC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPROTEIN; PROSTACYCLIN SYNTHASE;

ARTIFICIAL NEURAL NETWORK; FAMILY STUDY; GENE FUNCTION; GENE MAPPING; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; MEDICAL TECHNOLOGY; MONOGENIC DISORDER; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; TWINS;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; HYPERTENSION; INTRAMOLECULAR OXIDOREDUCTASES; LINKAGE (GENETICS); RECEPTORS, ADRENERGIC;

EID: 0034103364     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200005000-00009     Document Type: Review

References (58)

1. 1 Luft FC. Molecular genetics of human hypertension. J Hypertens 1998; 16:1871-1878.
2. 2 Gavras I, Manolis A, Gavras H. Genetic epidemiology of essential hypertension. J Hum Hypertens 1999; 13:225-229.
3. 3 Pradervand S, Wang Q, Burnier M, Beermann F, Horisberger JD, Hummler E, Rossier BC. A mouse model for Liddle's syndrome. J Am Soc Nephrol 1999; 10:2527-2533. This unique mouse model will be useful for the study of the human disease.
4. 1 and γ subunit proteins in rat kidney. J Clin Invest 1999; 104:R19-R23.
5. 5 Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999; 285:103-106. This study is the first to shed important genetic light on how the kidney handles magnesium.
6. 6 Barroso I, Gurnell M, Crowley VEF, Agostini M, Schwabe JW, Soos MA, et al. Dominant negative mutations in human PPARg associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999; 402:880-883. An exciting report of a new gene for diabetes and hypertension.
7. 7 Knoblauch H, Busjahn A, Mller-Myhsok B, Faulhaber H-D, Schuster H, Uhlmann R, Luft FC. Peroxisome proliferator activated protein γ gene locus, body mass index and lipid values in normal subjects. Arterioscler Thromb Vasc Biol 1999; 19:2940-2944.
8. 8 DeStefano AL, Baldwin CT, Burzstyn M, Gavras I, Hande DE, Joost O, et al. Autosomal dominant orthostatic hypotensive disorder maps to chromosome 18q. Am J Hum Genet 1998; 63:1425-1430. An important mapping study of a new 'low blood pressure' locus.
9. 9 Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I. Orthostatic intolerance in tachycardia associated with norepinephrine-transporter deficiency. New Engl J Med 2000; 342:541-549.
10. 10 Schwartz F, Baldwin CT, Baima J, Gavras H. Mitochondrial DNA mutations in patients with orthostatic hypotension. Am J Med Genet 1999; 86:145-150.
11. 11 Baima J, Nicolaou M, Schwartz F, DeStefano AL, Manolis A, Gavras I, et al. Evidence for linkage between essential hypertension and a putative locus on human chromosome 17. Hypertension 1999; 34:4-7. If rat studies will provide any useful information, synteny must be shown. This human linkage study succeeded.
12. 12 Xu X, Yang J, Rogus J, Chen C, Schork N, Xu X. Mapping of a blood pressure quantitative trait locus to chromosome 15q in a Chinese population. Hum Mol Genet 1999; 8:2551-2555.
13. 13 Xu X, Rogus JJ, Terwedow HA, Yang J, Wang Z, Chen C, et al. An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet 1999; 64:1694-1701.
14. 14 Niu T, Xu X, Cordell HJ, Rogus J, Zhou Y, Fang Z, Lindpaintner K. Linkage analysis of candidate genes and gene-gene interactions in Chinese hypertensive sib-pairs. Hypertension 1999; 33:1332-1337.
15. 15 Wong ZY, Stebbing M, Ellis JA, Lamantia A, Harrap SB. Genetic linkage of beta and gamma subunits of epithelial sodium channel to systolic blood pressure. Lancet 1999; 353:1222-1225. Interesting paper showing that the Liddle gene locus is a QTL for blood pressure in normal subjects.
16. 16 Nagy Z, Busjahn A, Bhring S, Faulhaber HD, Gohlke HR, Knoblauch H, et al. Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man. J Am Soc Nephrol 1999; 10:1709-1716. This study shows that twin genetics is highly useful for finding blood pressure and other QTL.
17. 17 Busjahn A, Aydin A, von Treuenfels N, Faulhaber HD, Gohlke HR, Knoblauch H, et al. Linkage but lack of association for blood pressure and the alpha-adducin locus in normotensive twins. J Hypertens 1999; 17:1437-1441.
18. 18 Takami S, Wong ZYH, Stebbing M, Harrap SB. Linkage analysis of endothelial nitric oxide synthase gene with human blood pressure. J Hypertens 1999; 17:1431-1436.
19. 19 Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999; 21:76-83. High tech approach enabled the rat doctors to finally clone a gene. The relevance to hypertension remains to be proved.
20. 20 Pravenec M, Zidek V, Simakova M, Kren V, Krenova D, Horky K, et al. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J Clin Invest 1999; 103:1651-1657. A nice demonstration of the power inherent in congenic strains.
21. 21 Anonymous. Freely associating. Nat Genet 1999; 22: 1-2. All investigators involved in association studies must read this editorial.
22. 22 Turner ST, Boerwinkle E, Sing CF. Context-dependent assocation of the ACE I/D polymorphism with blood pressure. Hypertension 1999; 34:773-778.
23. 23 Rieder MJ, Taylor SL, Clark AG, Nickerson DA. Sequence variation in the human angiotensin converting enzyme. Nat Genet 1999; 22:59-62. This study of the ACE gene shows how variable genes are in the normal population.
24. 24 Fardella C, Zamorano P, Mosso L, Gomez L, Pinto M, Soto J, et al. A 6G variant of angiotensinogen gene and aldosterone levels in hypertensives. Hypertension 1999; 34:779-781.
25. 25 Schorr U, Blaschke K, Beige J, Distler A, Sharma AM. Angiotensinogen M235T variant and salt sensitivity in young normotensive caucasians. J Hypertens 1999; 17:475-479.
26. 26 Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y. Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies. J Hypertens 1999; 17:757-763. A careful association study and subsequent meta-analysis of angiotensinogen in Japanese patients.
27. 27 Katsuya T, Higaki J, Ishikawa K, Sato N, Ogihara T. Genetic analysis of candidate gene polymorphisms in elderly hypertension. Nippon Onen Igakkai Zasshi 1999; 36:547-552.
28. 28 Corvol P, Persu A, Gimenez-Roqueplo A-P, Jeunemaitre X. Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. Hypertension 1999; 33:1324-1331. Worthwhile lessons from masters in the field.
29. 29 Nakajima T, Cheng T, Rohrwasser A, Bloem LJ, Pratt JH, Inoue I, Lalouel JM. Functional analysis of a mutation occurring between the two in-frame AUG codons of human angiotensinogen. J Biol Chem 1999; 274:35749-35755.
30. 30 Ambrosius WT, Bloem LJ, Zhou L, Rebhun JF, Snyder PM, Wagner MA, et al. Genetic variants in the epithelial sodium channel in relation to aldosterone and potassium excretion and risk for hypertension. Hypertension 1999; 34:631-637.
31. 31 Persu A, Coscoy S, Houot A-M, Corvol P, Barbry P, Jeunemaitre X. Polymorphisms of the g subunit of the epithelial Na+ channel in essential hypertension. J Hypertens 1999; 17:639-645.
32. 32 Abriel H, Loffing J, Rebhun JF, Pratt JH, Schild L, Horisberger JD, et al. Defective regulation of the epithelial Na+ channel by Nedd4 in Liddle¥s syndrome. J Clin Invest 1999; 103:667-673.
33. 33 Ferrandi M, Salardi S, Tripodi G, Barassi P, Rivera R, Manunta P, et al. Evidence for an interaction between adducin and the Na+-K+-ATPase: relation to genetic hypertension. Am J Physiol 1999; 277:H1338-HZ1349.
34. 34 Glorioso N, Manunta P, Filigheddu F, Troffa C, Stella P, Barlassina C, et al. The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 1999; 34:649-654. A double association study at two different locations.
35. 35 Hatakayama H, Inaba S, Miyamori I. 11 b-hydroxysteroid dehydrogenase in cultured human vascular cells. Hypertension 1999; 33:1179-1184.
36. 36 Lovati E, Ferrari P, Dick B, Jostarndt K, Frey BM, Frey FJ, et al. Molecular basis of human salt sensitivity: the role of the 11b-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metabol 1999; 84:3745-3749. An important intermediary phenotype is elucidated in this study.
37. 37 Lin RCY, William YS, Morris BJ. Association and linkage analyses of glucocorticoid receptor gene markers in essential hypertension. Hypertension 1999; 34:1186-1192.
38. 38 Siffert W, Rosskopf D, Erbel R, Ritz E. G protein beta3subunit 825T allele and hypertension. Hypertension 1999; 34:e8.
39. 39 Baumgart D, Naber C, Haude M, Oldenburg O, Erbel R, Heusch G, Siffert W. G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ Res 1999; 85:965-969. Highly interesting functional data in this 'bottom up' association study.
40. 40 Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C, et al. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999; 10:1921-1930.
41. 41 Jacobi J, Hilgers KF, Schlaich MP, Siffert W, Schmieder RE. 85T allele of the G-protein b3 subunit (GNB3) is associated with impaired left ventricular diastolic filling in essential hypertension. J Hypertens 1999; 17:1457-1462.
42. 42 Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP. Association between the C825T polymorphism of the G protein B3-subunit gene and hypertension in blacks. Hypertension 1999; 34:1193-1196. Most convincing association study to date on the beta3 subunit gene.
43. 43 Jia H, Hingorani AD, Sharma P, Hopper R, Dickerson C, Trutwein D, et al. Association of the Gsa gene with essential hypertension and response to b-blockade. Hypertension 1999; 34:8-14.
44. 44 Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, Yazaki Y. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 1999; 33:933-936.
45. 45 Glenn CL, Wang WY, Morris BJ. Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives. Hypertension 1999; 33:927-932.
46. 46 Herlitz H, Jungerstein LU, Wikstrand J, Widgren BR. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension. Kidney Int 1999; 56:1838-1845.
47. 47 Tiret L, Poirier O, Hallet V, McDonagh TA, Morrison C, McMurray JJV, et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999; 33:1169-1174.
48. 48 Iwai N, Katsuya T, Ishikawa K, Mannami T, Ogata J, Higaki J, et al. Human prostacyclin synthase gene and hypertension: The Suita Study. Circulation 1999; 100:2231-2236. Very interesting functional data on this prostacyclin synthase gene variant subjected it to a convincing association study.
49. 49 Brand E, Bankir L, Plouin P-F, Soubrier F. Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension: the PEGASE Study. Hypertension 1999; 34:15-17.
50. 50 Paolisso G, Tagliamonte MR, Galderisi M, Zito GA, Petrocelli A, Carella C, et al. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. Hypertension 1999; 34:1047-1052.
51. 51 Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metabol 1999; 84:3686-3695.
52. 52 Büscher R, Herrmann V, Ring KM, Kailasam MT, O'Connor DT, Parmer RJ, Insel PA. Variability in phenylephrine response and essential hypertension: a search for human a1b-adrenergic receptor polymorphisms. J Pharm Exp Ther 1999; 291:793-798.
53. 53 Makaritsis KP, Handy DE, Johns C, Kobilka B, Gavras I, Gavras H. Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension. Hypertension 1999; 33:14-17.
54. 54 Baldwin CT, Schwartz F, Baima J, Burzstyn M, DeStefano AL, Gavras I, et al. Indentification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertension. Am J Hypertens 1999; 12:853-7.
55. 55 Makaritsis KP, Johns C, Gavras I, Altman JD, Handy DE, Bresnahan MR, Gavras H. Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype. Hypertension 1999; 34:403-407.
56. 56 Busjahn A, Li G-H, Faulhaber H-D, Rosenthal M, Jeschke E, Schuster H, et al. b-2 adrenergic receptor gene variations, heart size, and blood pressure in normal twins. Hypertension 2000; 35:555-560. This combined linkage and association study investigates four polymorphisms simultaneously.
57. 57 Bowden AC. Metabolic control analysis in biotechnology and medicine. Nat Biotechnol 1999; 17:641-643. Important lessons in this editorial on dealing with complex genetic traits.
58. 58 Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999; 9:936-949. New insights into approaches for genotyping cardiovascular-relevant genes.